Variación biológica de lípidos y lipoproteínas séricas en individuos sanos y pacientes con enfermedad renal crónica terminal
Corte Arboleya, Zoraida; Venta Obaya, Rafael.
Rev. lab. clín
; 7(3): 88-95, jul.-sept. 2014.
Artículo en Español | IBECS (España) | ID: ibc-128921
Documentos relacionados
Control of residual dyslipidaemic risk.
Unmasking the morphological alteration of erythrocytes among women suffering from PCOS.
[Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease].
Obesity and Dyslipidemia.
Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Exploring the bi-directional relationship between periodontitis and dyslipidemia: a comprehensive systematic review and meta-analysis.
THE SIGNIFICANCE OF CIRCULATING SURFACTANT PROTEIN D AND DYSLIPIDEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, CORONARY HEART DISEASE AND THEIR COMBINATION.
Periodontitis is a factor associated with dyslipidemia.
[Management of obesity-associated dyslipidemia : an approach based on food choices].
Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease.